PACIRA BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
PACIRA BIOSCIENCES, INC. (PCRX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 41.51 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-02-21
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 41.78M shares, a 1.55% increase year-over-year.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 41.65M shares, a 1.59% increase year-over-year.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-12-31 was 41.15M shares, a 1.33% increase year-over-year.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 40.99M shares, a 1.31% increase year-over-year.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 41.51M shares, a 1.47% increase from fiscal 2018.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 40.91M shares, a 2.78% increase from fiscal 2017.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 39.81M shares, a 6.90% increase from fiscal 2016.
- PACIRA BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 37.24M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 41.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | 41.71M shares derived: average of 2 quarters · filed 2020-02-21 | 41.51M shares 10-K · filed 2020-02-21 | |||||
| 2019-09-30 | 41.65M shares 10-Q · filed 2019-11-08 | 41.42M shares 10-Q · filed 2019-11-08 | ||||||
| 2018-12-31 | 41.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | 41.07M shares derived: average of 2 quarters · filed 2020-02-21 | 40.91M shares 10-K · filed 2020-02-21 | |||||
| 2018-09-30 | 40.99M shares 10-Q · filed 2019-11-08 | 40.83M shares 10-Q · filed 2019-11-08 | ||||||
| 2018-03-31 | 40.71M shares 10-Q · filed 2018-05-03 | 40.66M shares derived: average of 2 quarters · filed 2020-02-21 | 40.59M shares derived: average of 3 quarters · filed 2020-02-21 | 40.48M shares derived: average of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | 40.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | 40.53M shares derived: average of 2 quarters · filed 2020-02-21 | 40.41M shares derived: average of 3 quarters · filed 2020-02-21 | 39.81M shares 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | 40.46M shares 10-Q · filed 2017-11-08 | 40.31M shares derived: average of 2 quarters · filed 2017-11-08 | 39.54M shares 10-Q · filed 2017-11-08 | 39.01M shares derived: average of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | 40.16M shares 10-Q · filed 2017-08-02 | 39.08M shares 10-Q · filed 2017-08-02 | 38.53M shares derived: average of 3 quarters · filed 2019-02-28 | 38.23M shares derived: average of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | 38.00M shares 10-Q · filed 2018-05-03 | 37.71M shares derived: average of 2 quarters · filed 2019-02-28 | 37.58M shares derived: average of 3 quarters · filed 2019-02-28 | 37.48M shares derived: average of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | 37.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 37.37M shares derived: average of 2 quarters · filed 2019-02-28 | 37.31M shares derived: average of 3 quarters · filed 2019-02-28 | 37.24M shares 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | 37.31M shares 10-Q · filed 2017-11-08 | 37.25M shares derived: average of 2 quarters · filed 2017-11-08 | 37.17M shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 37.18M shares 10-Q · filed 2017-08-02 | 37.10M shares 10-Q · filed 2017-08-02 | ||||||
| 2016-03-31 | 37.02M shares 10-Q · filed 2017-05-04 | |||||||
| 2014-12-31 | 36.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 36.01M shares derived: average of 2 quarters · filed 2015-02-24 | 35.83M shares derived: average of 3 quarters · filed 2015-02-24 | 35.30M shares 10-K · filed 2015-02-24 | ||||
| 2014-09-30 | 35.94M shares 10-Q · filed 2014-10-30 | 35.70M shares derived: average of 2 quarters · filed 2014-10-30 | 35.04M shares 10-Q · filed 2014-10-30 | 34.67M shares derived: average of 4 quarters · filed 2015-02-24 | ||||
| 2014-06-30 | 35.46M shares 10-Q · filed 2014-07-31 | 34.59M shares 10-Q · filed 2014-07-31 | 34.25M shares derived: average of 3 quarters · filed 2015-02-24 | 34.03M shares derived: average of 4 quarters · filed 2015-02-24 | ||||
| 2014-03-31 | 33.71M shares 10-Q · filed 2014-05-01 | 33.64M shares derived: average of 2 quarters · filed 2015-02-24 | 33.55M shares derived: average of 3 quarters · filed 2015-02-24 | 33.43M shares derived: average of 4 quarters · filed 2015-02-24 | ||||
| 2013-12-31 | 33.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 33.47M shares derived: average of 2 quarters · filed 2015-02-24 | 33.34M shares derived: average of 3 quarters · filed 2015-02-24 | 33.18M shares 10-K · filed 2015-02-24 | 33.18M shares 10-K · filed 2014-02-25 | |||
| 2013-09-30 | 33.36M shares 10-Q · filed 2014-10-30 | 33.36M shares 10-Q · filed 2013-10-31 | 33.22M shares derived: average of 2 quarters · filed 2014-10-30 | 33.05M shares 10-Q · filed 2014-10-30 | 33.05M shares 10-Q · filed 2013-10-31 | 32.93M shares derived: average of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | 33.08M shares 10-Q · filed 2014-07-31 | 33.08M shares 10-Q · filed 2013-08-06 | 32.90M shares 10-Q · filed 2014-07-31 | 32.90M shares 10-Q · filed 2013-08-06 | 32.79M shares derived: average of 3 quarters · filed 2015-02-24 | 32.70M shares derived: average of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | 32.71M shares 10-Q · filed 2014-05-01 | 32.64M shares derived: average of 2 quarters · filed 2015-02-24 | 32.57M shares derived: average of 3 quarters · filed 2015-02-24 | 32.17M shares derived: average of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | 32.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | 32.50M shares derived: average of 2 quarters · filed 2015-02-24 | 31.99M shares derived: average of 3 quarters · filed 2015-02-24 | 30.33M shares 10-K · filed 2015-02-24 | 30.33M shares 10-K · filed 2013-03-07 | |||
| 2012-09-30 | 32.44M shares 10-Q · filed 2013-10-31 | 31.69M shares derived: average of 2 quarters · filed 2013-10-31 | 29.59M shares 10-Q · filed 2013-10-31 | 27.51M shares derived: average of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | 30.95M shares 10-Q · filed 2013-08-06 | 28.16M shares 10-Q · filed 2013-08-06 | 25.86M shares derived: average of 3 quarters · filed 2014-02-25 | 23.71M shares derived: average of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | 25.37M shares 10-Q · filed 2013-05-08 | 23.32M shares derived: average of 2 quarters · filed 2014-02-25 | 21.29M shares derived: average of 3 quarters · filed 2014-02-25 | 20.28M shares derived: average of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | 21.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | 19.25M shares derived: average of 2 quarters · filed 2014-02-25 | 18.58M shares derived: average of 3 quarters · filed 2014-02-25 | 16.44M shares 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | 17.23M shares 10-Q · filed 2012-11-01 | 17.23M shares derived: average of 2 quarters · filed 2012-11-01 | 14.83M shares 10-Q · filed 2012-11-01 | |||||
| 2011-06-30 | 17.23M shares 10-Q · filed 2012-08-09 | 13.62M shares 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | 574.07K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |